Middle Molecule Find

Rulebook › V-tags › V358

V358 Clinical results: URR or Kt/V over time

Written V0358 on the CMS-2567 and in QCOR.

Enforces ANSI/AAMI RD47:2002/A1:2003, adopted by reference at 42 CFR 494.50(b)(1) · Appendix H Rev. 246, page 176 · checked 12 Nov 2026

Cited on this tag? What happens after a citation · One-page sheet for the binder

The regulation

ANSI/AAMI RD47:2002/A1:2003 Requirements as Adopted by Reference 42 CFR 494.50(b)(1)

13.4 Clinical results (monitoring patient results; Kt/V)

Monitoring of relevant patient results is recommended to ensure that all parameters relating to hemodialyzer clearance are being met. Specifically, examination of urea reduction ratio (URR) or Kt/V over time is necessary. The failure of these results to meet the expectations of the dialysis prescription should be investigated. Deterioration of a patient’s clinical condition or variability of routine dialysis procedures (heparinization, ultrafiltration, dose of erythropoietin stimulating agent) [requires] an investigation of all practices, including reuse. Reports of investigations should be filed in the complaint log.

CMS's interpretive guidance

Interpretive Guidance § 494.50(b)(1)

AAMI Rationale for the Development and Provisions of this Recommended Practice

A.13.4 Clinical results

Critical assessment of chemistries and the delivered dose of dialysis (Kt/V or urea reduction ratio), as is done monthly, provides a clear trend line to assess treatment. This scrutiny of the patient’s treatment and course is the primary confirmation that hemodialyzer performance anticipated from TCV or other indirect estimation is accurate and adequate. The overall effectiveness of the entire treatment, not only the clearance of the dialyzers, is measured. No other measure of the effectiveness of new or reused dialyzers is as clear or relevant. Trend lines developed from this data characterize the quality of therapy. . . If the practitioner has concerns for “middle molecules” or other clinical parameters, these factors should also be part of the assessment of the delivered therapy.

There are many reasons for an apparent reduction in the mass transfer of urea, other than decreased hemodialyzer clearance as a result of inadequate reprocessing (such as recirculation, decreased dialysis time or blood flow rate, or an inappropriate dialysis prescription). To document adequate mass transfer, parallel measurements of pre- and post-creatinine levels are helpful. When problems develop with any patient or group of patients, monitoring intensity should be increased, and other methods should be used to analyze the problem and define corrective action.

Verbatim from Appendix H Rev. 246, with CMS's headings, lists and bold. Check page 176 (the full 469-page PDF) before quoting it.